OSR2
Protein odd-skipped-related 2
Also known as: FLJ90037, OSR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N2R0
- Gene
- OSR2
- Ensembl
- ENSG00000164920
- Chromosome
- 8
- Canonical length
- 312 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
OSR2 is a mammalian homolog of the Drosophila odd-skipped family of transcription factors (Lan et al., 2004 [PubMed 15175245]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
312 residues, UniProt reviewed canonical sequence.
>Q8N2R0|OSR2
1 MGSKALPAPI PLHPSLQLTN YSFLQAVNTF PATVDHLQGL YGLSAVQTMH MNHWTLGYPN
61 VHEITRSTIT EMAAAQGLVD ARFPFPALPF TTHLFHPKQG AIAHVLPALH KDRPRFDFAN
121 LAVAATQEDP PKMGDLSKLS PGLGSPISGL SKLTPDRKPS RGRLPSKTKK EFICKFCGRH
181 FTKSYNLLIH ERTHTDERPY TCDICHKAFR RQDHLRDHRY IHSKEKPFKC QECGKGFCQS
241 RTLAVHKTLH MQESPHKCPT CGRTFNQRSN LKTHLLTHTD IKPYSCEQCG KVFRRNCDLR
301 RHSLTHTPRQ DFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OSR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 162 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 162 nTPM
- fallopian tube: 152 nTPM
- cervix: 150 nTPM
- ovary: 89 nTPM
- vagina: 79 nTPM
- seminal vesicle: 68 nTPM
Single-cell type
- decidual stromal cells: 1,198 nCPM
- peritubular myoid cells: 813 nCPM
- leydig cells: 725 nCPM
- ovarian stromal cells: 248 nCPM
- extravillous trophoblasts: 228 nCPM
- endometrial stromal cells: 206 nCPM
Immune cell
- eosinophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1 nTPM
- cerebral cortex: 0.9 nTPM
- hippocampal formation: 0.5 nTPM
- amygdala: 0.4 nTPM
- choroid plexus: 0.4 nTPM
- pons: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 1.83
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone morphogenesis
- cell differentiation
- chondrocyte differentiation
- embryo development ending in birth or egg hatching
- embryonic digit morphogenesis
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- embryonic skeletal joint development
- embryonic skeletal joint morphogenesis
- embryonic skeletal limb joint morphogenesis
- embryonic skeletal system morphogenesis
- eyelid development in camera-type eye
- head development
- mesonephros development
- metanephros development
- middle ear morphogenesis
- negative regulation of transcription by RNA polymerase II
- odontogenesis
- osteoblast proliferation
- pattern specification process
- positive regulation of bone mineralization
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of epithelial cell proliferation
- positive regulation of gene expression
- positive regulation of stem cell proliferation
- positive regulation of transcription by RNA polymerase II
- pronephros development
- roof of mouth development
- stem cell proliferation
- urogenital system development
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OSR2 as an antibody target. Whether an autoantibody or antibody against OSR2 could matter depends on whether native OSR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OSR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OSR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...